Ranitidine

Manufacturer: Dr. Reddy's Laboratories Limited
Effective date: 2025-05-23
Label type: HUMAN OTC DRUG LABEL
Version: 12
Source: full-release
Hydrated at: 2026-06-01 01:01:52

Label at a glance#

ProductRanitidine

Active ingredientRanitidine Hydrochloride

Label structure13 sections

Dosage and administration

adults and children 12 years and over: to relieve symptoms, swallow 1 tablet with a glass of water to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn can be used up to twice daily (do not take more than 2 tablets in 24 hours) children under 12 years: ask a doctor

Contacts and useful links#

PhonePoison Help1-800-222-1222

PhoneLabel contact1-888-375-3784

Label contents#

Full prescribing information#

SPL PRODUCT DATA ELEMENTS SECTION

SPL UNCLASSIFIED SECTION

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Ranitidine 150 mg (as ranitidine hydrochloride USP, 168 mg)

Purpose

OTC - PURPOSE SECTION

Acid reducer

Use(s)

INDICATIONS & USAGE SECTION

relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages

Warnings

WARNINGS SECTION

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do not use

OTC - DO NOT USE SECTION

if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.These may be signs of a serious condition. See your doctor.
with other acid reducers

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lightheadedness, sweating or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
frequent chest pain
frequent wheezing, particularly with heartburn
unexplained weight loss
nausea or vomiting
stomach pain
kidney disease

Ask a doctor or pharmacist before use if you are

SPL UNCLASSIFIED SECTION

• taking a prescription drug. Acid reducers may interact with certain prescription drugs.

Stop use and ask doctor if

OTC - STOP USE SECTION

your heartburn continues or worsens
you need to take this product for more than 14 days

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 12 years and over:
- to relieve symptoms, swallow 1 tablet with a glass of water
- to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
- can be used up to twice daily (do not take more than 2 tablets in 24 hours)
children under 12 years: ask a doctor

Other information

SPL UNCLASSIFIED SECTION

do not use if printed foil under bottle cap is open or torn
store at 20°-25°C (68°-77°F)
avoid excessive heat or humidity
protect from light
this product is sodium and sugar free

Inactive ingredients

INACTIVE INGREDIENT SECTION

FD&C red #40 aluminum lake, hypromellose, iron oxide black, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.

Questions?

OTC - QUESTIONS SECTION

Call 1-888-375-3784

Read the directions and warnings before use. Keep the carton. It contains important information including tips for managing heartburn.

SPL UNCLASSIFIED SECTION

Tips for managing heartburn

Do not lie flat or bend over soon after eating
Do not eat late at night, or just before bedtime
Certain foods or drinks are more likely to cause heartburn, such as rich, spicy, fatty, and fried foods, chocolate, caffeine, alcohol, and even some fruits and vegetables.
Eat slowly and do not eat beig meals
If you are overweight, lose weight
If you smoke, quit smoking
Raise the head of your bed
Wear loose fitting clothing around your stomach.

Revised: 03/20

PACKAGE LABEL PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Container Label:

Dr.Reddy's
NDC 55111-404-34

Maximum Strength
Ranitidine
Tablets USP,150 mg
ACID REDUCER

PREVENTS & RELIEVES
HEARTBURN associated with acid indigestion
and sour stomach

24 Tablets(24 doses)

container

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Container Carton Label:

Dr.Reddy's
NDC 55111-404-34

Compare to the active
ingredient in Zantact 150^® Tablets*

Maximum Strength
Ranitidine
Tablets USP,150 mg
ACID REDUCER

PREVENTS & RELIEVES
heartburn associated with acid indigestion
and sour stomach

24 Tablets(24 doses)

containercarton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Blister Carton Label:

Dr.Reddy's
NDC 55111-404-24

Maximum Strength
Ranitidine
Tablets USP,150 mg
ACID REDUCER

PREVENTS & RELIEVES
HEARTBURN associated with acid indigestion
and sour stomach

24 Tablets(24 doses)

blistercarton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
198191	ranitidine 150 MG Oral Tablet	PSN	12
198191	ranitidine 150 MG Oral Tablet	SCD	12
198191	ranitidine 150 MG (as ranitidine HCl 168 MG) Oral Tablet	SY	12

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
RANITIDINE Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7f54af34-be54-4c3c-894f-78df6452d747	Product name	3	20190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850	Product name	5	20190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7b	Product name	1	20180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228	Product name	1	20160720

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55111-404-34	EA - Each	55111-404	77f8c9e5-f9d2-4d80-88c6-7059a252ae06	1	2015-09-10

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Ranitidine Hydrochloride	ACTIVE INGREDIENT	BK76465IHM	6
RANITIDINE	ACTIVE MOIETY	884KT10YB7	6
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	6
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	6
FERROSOFERRIC OXIDE	INACTIVE INGREDIENT	XM0M87F357	6
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	6
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	6
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	6
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	6

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

Ranitidine
Ranitidine Hydrochloride
FD&C RED NO. 40
HYPROMELLOSE 2910 (6 MPA.S)
FERROSOFERRIC OXIDE
magnesium stearate
cellulose, microcrystalline
POLYETHYLENE GLYCOL 400
titanium dioxide

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
55111-404	55111-404-34, 55111-404-32, 55111-404-36, 55111-404-50, 55111-404-61, 55111-404-55, 55111-404-62, 55111-404-90, 55111-404-02, 55111-404-65, 55111-404-17, 55111-404-24, 55111-404-38, 55111-404-40

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Ranitidine Hydrochloride	BK76465IHM	ACTIM
FD&C RED NO. 40	WZB9127XOA	IACT
HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	IACT
FERROSOFERRIC OXIDE	XM0M87F357	IACT
magnesium stearate	70097M6I30	IACT
cellulose, microcrystalline	OP1R32D61U	IACT
POLYETHYLENE GLYCOL 400	B697894SGQ	IACT
titanium dioxide	15FIX9V2JP	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 330 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED / ORAL	20 mg		Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, DELAYED RELEASE / ORAL		35 mg	Exact identifier — unii+route 240 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, COATED / ORAL	NA		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, COATED / ORAL	0.1 mg		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION, CONCENTRATE / ORAL		2813 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED / ORAL	20 mg		Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SYRUP / ORAL		740 mg	Exact identifier — unii+route 240 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, EXTENDED RELEASE / ORAL		60 mg	Exact identifier — unii+route 240 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, COATED / ORAL	0.1 mg		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 240 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SUSPENSION / ORAL		400 mg	Exact identifier — unii+route 240 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, COATED / ORAL		12 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET / ORAL		193 mg	Exact identifier — unii+route 240 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE, LIQUID FILLED / ORAL		1122 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CONCENTRATE / ORAL		3000 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, ORALLY DISINTEGRATING / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / ORAL		70200 mg	Exact identifier — unii+route 240 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, COATED / ORAL	0.1 mg		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION, CONCENTRATE / ORAL		2813 mg	Exact identifier — unii+route 240 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, COATED / ORAL	NA		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, COATED / ORAL	NA		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET / ORAL		193 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE, LIQUID FILLED / ORAL		1122 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SYRUP / ORAL		740 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET / ORAL		193 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SYRUP / ORAL		740 mg	Exact identifier — unii+route 240 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, COATED / ORAL	NA		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED / ORAL	20 mg		Exact identifier — unii+route 240 equally ranked IID candidates
titanium dioxide	TITANIUM DIOXIDE	15FIX9V2JP	TABLET, COATED / ORAL		49 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION, CONCENTRATE / ORAL		2813 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE, LIQUID FILLED / ORAL		1122 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION / ORAL		70200 mg	Exact identifier — unii+route 240 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CONCENTRATE / ORAL		3000 mg	Exact identifier — unii+route 240 equally ranked IID candidates
cellulose, microcrystalline	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, COATED / ORAL		920 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, COATED / ORAL	0.1 mg		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED / ORAL	20 mg		Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SYRUP / ORAL		740 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SYRUP / ORAL		740 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE, LIQUID FILLED / ORAL		1122 mg	Exact identifier — unii+route 240 equally ranked IID candidates
FERROSOFERRIC OXIDE	FERROSOFERRIC OXIDE	XM0M87F357	TABLET, COATED / ORAL	NA		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
FD&C RED NO. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, COATED / ORAL	0.1 mg		Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	CAPSULE, EXTENDED RELEASE / ORAL		17 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET / ORAL		193 mg	Exact identifier — unii+route 240 equally ranked IID candidates
HYPROMELLOSE 2910 (6 MPA.S)	HYPROMELLOSE 2910 (6 MPA.S)	0WZ8WG20P6	TABLET, COATED / ORAL		12 mg	Exact identifier — unii+route+dosage form 15 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	SOLUTION, CONCENTRATE / ORAL		2813 mg	Exact identifier — unii+route 240 equally ranked IID candidates
POLYETHYLENE GLYCOL 400	POLYETHYLENE GLYCOL 400	B697894SGQ	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		2 mg	Exact identifier — unii+route 240 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A078192-001	RANITIDINE HYDROCHLORIDE	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL			2007-08-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A078192-001	RANITIDINE HYDROCHLORIDE	EQ 150MG BASE	TABLET / ORAL	2007-08-31	`f41ea6bd6efb…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ranitidine	RANITIDINE	Dr. Reddy's Laboratories Limited	00df8a42-296f-80dd-98af-ee8b30eb38cc	2025-05-23	Warnings	Exact identifier ndc (package): 55111-404-17 ndc (package): 55111-404-36 ndc (package): 55111-404-61 ndc (package): 55111-404-55 ndc (package): 55111-404-65 ndc (package): 55111-404-02 ndc (package): 55111-404-38 ndc (package): 55111-404-32 ndc (package): 55111-404-24 ndc (package): 55111-404-62 ndc (package): 55111-404-34 ndc (package): 55111-404-50 ndc (package): 55111-404-40 ndc (package): 55111-404-90 ndc (product): 55111-404 ndc11 (package): 55111040424 ndc11 (package): 55111040432 ndc11 (package): 55111040490 ndc11 (package): 55111040455 ndc11 (package): 55111040402 ndc11 (package): 55111040434 ndc11 (package): 55111040462 ndc11 (package): 55111040436 ndc11 (package): 55111040440 ndc11 (package): 55111040438 ndc11 (package): 55111040417 ndc11 (package): 55111040450 ndc11 (package): 55111040461 ndc11 (package): 55111040465 spl id: c47f1d10-c4d9-5df4-84e8-55956b47568b spl set id: 00df8a42-296f-80dd-98af-ee8b30eb38cc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.